Market Access for Medical Technologies in Belgium

In October 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices. A new sub-chapter with multiple material codes for the reconstruction of large bone defects and a new sub-chapter with a material code for a pre-formed periarticular osteosynthesis plate were introduced. Two new Nominative lists for brand-specific devices for the reconstruction of large bone defects were also published.

On September 8, 2025, the FPS Public Health opened the “Reducing Single-Use in Hospitals (ReSUH)” call, inviting accredited general, psychiatric, and university hospitals to implement concrete measures to reduce single-use medical products within a broader sustainability strategy.

In September 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the list of reimbursable companion diagnostics. A new clinical indication, urothelial carcinoma, was introduced, with two new predictive biomarker tests included in the List.